Novartis Türkiye and Tenity have announced a new strategic partnership aimed at fostering innovation in healthcare by connecting startups with real industry challenges and expertise.
The collaboration brings together Novartis’ global leadership in healthcare and deep local presence in Türkiye with Tenity’s experience in building and scaling startup ecosystems across fintech, technology, and innovation-driven industries. Together, the partners will launch a health-focused innovation program designed to support startups developing solutions that improve healthcare engagement, accessibility, and patient-centered experiences.
The program will invite Healthtech and Fintech startups to work closely with Novartis Türkiye teams, gaining direct exposure to industry insights, real-world use cases, and collaboration opportunities. Selected startups will have the opportunity to present their solutions during a live event in Istanbul later this year, engaging with Novartis experts and key stakeholders from the innovation ecosystem.
At Novartis Türkiye, we believe innovation in healthcare can only be achieved through strong cross-border collaborations and shared ambitions,”
said Serkan Barış, Country President of Novartis Türkiye.
“The Health Innovation Program is a platform that brings together innovative ideas and scalable technologies from around the world with the dynamism of Türkiye’s healthcare ecosystem—shaping the future of healthcare and translating these solutions into tangible benefits for patients
“Partnership between Novartis Türkiye and Tenity is more than a strategic alignment; it is a powerful innovation bridge that merges Türkiye’s agile entrepreneurial spirit with Europe’s deep-rooted healthcare expertise.
By combining Novartis Türkiye’s scientific legacy with Tenity’s global acceleration expertise, we are creating a launchpad for solutions that solve real-world medical challenges. In our DNA, innovation means transforming digital health ideas into life-changing patient outcomes. Through this ecosystem, we are not only fueling the growth of healthtech startups but also providing them with the clinical validation and cross-border networking necessary to scale. We believe that the future of medicine lies at the intersection of collaboration and technology, and by fostering this ecosystem, we are ensuring that breakthrough health innovations can thrive from Türkiye to Switzerland and beyond.”
said Sabina Babayeva, Head of Istanbul Hub at Tenity.
Further details about the program, including focus areas and application timelines, will be announced in the coming weeks.
About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.
About Tenity
Tenity is a global innovation powerhouse shaping the future of finance and technology.
With hubs across Europe and Asia, Tenity blends venture capital, open innovation and global ecosystem access to create value that compounds. Since launch, it has partnered with over 65 institutions, supported 1,600+ startups, and runs innovation programs in 15+ countries.
Tenity. Fintech makers – and other impossible things
The call is intended solely for applications submitted within the scope of the Program and must not be used for any other purpose. Any use for purposes other than those specified shall not be considered binding for Novartis Türkiye.
